Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Price:
1 698
INR
-0.99%
Market Closed
Market Cap:
₹4.1T
Cash Flow Statement
Cash Flow Statement
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Currency: INR
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
50 096
|
16 621
|
27 994
|
71 568
|
44 813
|
50 879
|
94 084
|
99 832
|
110 879
|
128 373
|
137 521
|
140 711
|
|
| Depreciation & Amortization |
20 528
|
21 169
|
20 800
|
21 190
|
21 437
|
23 081
|
25 294
|
26 156
|
25 566
|
25 535
|
25 754
|
27 244
|
|
| Other Non-Cash Items |
(602)
|
2 041
|
(2 701)
|
(4 923)
|
(1 688)
|
1 179
|
1 931
|
(121)
|
(10 022)
|
(17 139)
|
(14 550)
|
(19 039)
|
|
| Cash Taxes Paid |
13 459
|
12 239
|
10 029
|
10 687
|
(9 692)
|
(10 199)
|
15 098
|
14 932
|
15 694
|
8 318
|
4 768
|
11 739
|
|
| Cash Interest Paid |
2 719
|
1 667
|
1 443
|
1 103
|
732
|
398
|
992
|
2 119
|
2 190
|
2 220
|
2 238
|
2 726
|
|
| Change in Working Capital |
(4 474)
|
7 440
|
15 612
|
(5 462)
|
25 697
|
(34 403)
|
(66 050)
|
(4 016)
|
(5 060)
|
(9 611)
|
(8 004)
|
(21 753)
|
|
| Cash from Operating Activities |
65 548
N/A
|
47 270
-28%
|
61 704
+31%
|
82 374
+33%
|
90 260
+10%
|
40 735
-55%
|
55 260
+36%
|
121 851
+121%
|
121 363
0%
|
127 158
+5%
|
140 721
+11%
|
127 163
-10%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(15 420)
|
(13 938)
|
(11 701)
|
(14 760)
|
(14 950)
|
(15 899)
|
(20 856)
|
(19 673)
|
(22 018)
|
(19 416)
|
(21 286)
|
(38 195)
|
|
| Other Items |
(10 468)
|
421
|
17 064
|
10 179
|
(42 297)
|
(44 235)
|
(58 581)
|
(36 267)
|
15 116
|
(23 263)
|
(31 776)
|
(55 934)
|
|
| Cash from Investing Activities |
(25 888)
N/A
|
(13 517)
+48%
|
5 362
N/A
|
(4 581)
N/A
|
(57 247)
-1 150%
|
(60 134)
-5%
|
(79 437)
-32%
|
(55 940)
+30%
|
(6 902)
+88%
|
(42 679)
-518%
|
(53 062)
-24%
|
(94 129)
-77%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(31 230)
|
(27 811)
|
(44 896)
|
(36 747)
|
(27 654)
|
15 506
|
49 950
|
(24 832)
|
(35 130)
|
4 503
|
(11 649)
|
22 596
|
|
| Cash Paid for Dividends |
(13 792)
|
(9 593)
|
(15 595)
|
(18 008)
|
(21 589)
|
(23 971)
|
(25 189)
|
(27 592)
|
(28 982)
|
(31 381)
|
(36 140)
|
(37 339)
|
|
| Other |
(12 130)
|
(5 771)
|
686
|
(4 523)
|
(2 692)
|
(513)
|
(1 001)
|
(2 142)
|
(2 990)
|
(32 036)
|
(31 270)
|
(2 726)
|
|
| Cash from Financing Activities |
(57 151)
N/A
|
(43 174)
+24%
|
(59 805)
-39%
|
(59 277)
+1%
|
(51 935)
+12%
|
(8 978)
+83%
|
23 761
N/A
|
(54 565)
N/A
|
(67 102)
-23%
|
(58 914)
+12%
|
(79 058)
-34%
|
(17 469)
+78%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
3 635
|
1 550
|
(1 297)
|
359
|
1 274
|
1 861
|
1 571
|
(277)
|
(740)
|
529
|
1 230
|
4 533
|
|
| Net Change in Cash |
(13 856)
N/A
|
(7 871)
+43%
|
5 964
N/A
|
18 873
+216%
|
(17 648)
N/A
|
(26 516)
-50%
|
1 155
N/A
|
11 069
+858%
|
46 619
+321%
|
26 094
-44%
|
9 831
-62%
|
20 098
+104%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
50 128
N/A
|
33 332
-34%
|
50 002
+50%
|
67 614
+35%
|
75 310
+11%
|
24 836
-67%
|
34 404
+39%
|
102 178
+197%
|
99 345
-3%
|
107 742
+8%
|
119 435
+11%
|
88 968
-26%
|
|
Switch to:
Switch to:
See Also
Discover More
